Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Chronic Heart Failure

Free Subscription 20.05.2024 5 Circ Heart Fail 1 Circ Res 1 Circulation 4 Eur Heart J 16 Eur J Heart Fail 5 Int J Cardiol 4 J Am Coll Cardiol 9 J Card Fail 2 J Thorac Cardiovasc Surg 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Circ Heart Fail

1. BANSAL N, Zelnick LR, Scherzer R, Estrella M, et al
   Risk Factors and Outcomes Associated With Heart Failure With Preserved and Reduced Ejection Fraction in People With Chronic Kidney Disease.
   Circ Heart Fail. 2024 May 14:e011173. doi: 10.1161/CIRCHEARTFAILURE.123.011173.
   PubMed         Abstract available
   
   
2. BHATT AS, Fiuzat M
   How Did We Score? Evaluating the Utility of a Score-Based System for Heart Failure Medical Therapy.
   Circ Heart Fail. 2024 May 14:e011654. doi: 10.1161/CIRCHEARTFAILURE.124.011654.
   PubMed        
   
   
3. ALBULUSHI A
   Letter by Albulushi Regarding Article, "Protocolized Natriuresis-Guided Decongestion Improves Diuretic Response in Acute Heart Failure: The Multicenter ENACT-HF Study".
   Circ Heart Fail. 2024 May 14:e011579. doi: 10.1161/CIRCHEARTFAILURE.124.011579.
   PubMed        
   
   
4. KOSYAKOVSKY LB, Liu EE, Wang JK, Myers L, et al
   Uncovering Unrecognized Heart Failure With Preserved Ejection Fraction Among Individuals With Obesity and Dyspnea.
   Circ Heart Fail. 2024 May 14:e011366. doi: 10.1161/CIRCHEARTFAILURE.123.011366.
   PubMed         Abstract available
   
   
5. SHAHRIAR AA, Allan TE, Belkin MN
   Letter by Shahriar et al Regarding Article, "Protocolized Natriuresis-Guided Decongestion Improves Diuretic Response in Acute Heart Failure: The Multicenter ENACT-HF Study".
   Circ Heart Fail. 2024 May 14:e011703. doi: 10.1161/CIRCHEARTFAILURE.124.011703.
   PubMed        
   
   

   
   Circ Res

6. LIEM DA, Olivera da Silva H, Romero E, Rocha P, et al
   Association of Neighborhood and Environmental Factors with Clinical Phenotypes and Outcomes in Heart Failure with Preserved Ejection Fraction.
   Circ Res. 2024 May 17. doi: 10.1161/CIRCRESAHA.124.324429.
   PubMed        
   
   

   
   Circulation

7. PACKER M, Anker SD, Butler J, Cleland JGF, et al
   Redefining Iron Deficiency in Patients With Chronic Heart Failure.
   Circulation. 2024 May 11. doi: 10.1161/CIRCULATIONAHA.124.068883.
   PubMed        
   
   

   
   Eur Heart J

8. CLEPHAS PRD, Zwartkruis VW, Malgie J, van Gent MWF, et al
   Pulmonary artery pressure monitoring in chronic heart failure: effects across clinically relevant subgroups in the MONITOR-HF trial.
   Eur Heart J. 2024 May 11:ehae323. doi: 10.1093.
   PubMed         Abstract available
   
   
9. PACKER M, Anker SD, Butler J, Cleland JGF, et al
   Identification of three mechanistic pathways for iron-deficient heart failure.
   Eur Heart J. 2024 May 11:ehae284. doi: 10.1093.
   PubMed         Abstract available
   
   
10. SHAH SJ, Sharma K, Borlaug BA, Butler J, et al
    Semaglutide and Diuretic Use in Obesity-Related Heart Failure with Preserved Ejection Fraction: A Pooled Analysis of the STEP-HFpEF and STEP-HFpEF-DM trials.
    Eur Heart J. 2024 May 13:ehae322. doi: 10.1093.
    PubMed         Abstract available
    
    
11. DUBIN RF, Deo R, Ren Y, Wang J, et al
    Incident heart failure in chronic kidney disease: proteomics informs biology and risk stratification.
    Eur Heart J. 2024 May 17:ehae288. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Eur J Heart Fail

12. ASSMUS B, Sossalla S
    What we claim to do and what we really do - a discrepancy in heart failure treatment.
    Eur J Heart Fail. 2024 May 13. doi: 10.1002/ejhf.3279.
    PubMed        
    
    
13. VERBRUGGE FH
    Pushing the limits of natriuresis for poor kidneys in acute heart failure?
    Eur J Heart Fail. 2024 May 13. doi: 10.1002/ejhf.3278.
    PubMed        
    
    
14. RICCARDI M, Borlaug BA, Inciardi RM
    Mitral regurgitation and heart failure with preserved ejection fraction: Should we treat the muscle, the valve, or both?
    Eur J Heart Fail. 2024 May 13. doi: 10.1002/ejhf.3288.
    PubMed        
    
    
15. PANICHELLA G, Tomasoni D, Aimo A
    Insulin-like growth factor binding protein-7 in heart failure: The challenge of moving from risk prediction to a biomarker-guided management.
    Eur J Heart Fail. 2024 May 13. doi: 10.1002/ejhf.3287.
    PubMed        
    
    
16. ESQUIVEL GAYTAN A, Bomer N, Grote Beverborg N, van der Meer P, et al
    404-error "Disease not found": Unleashing the translational potential of -omics approaches beyond traditional disease classification in heart failure research.
    Eur J Heart Fail. 2024 May 13. doi: 10.1002/ejhf.3268.
    PubMed         Abstract available
    
    
17. CURTAIN JP, Talebi A, McIntosh A, McConnachie A, et al
    Measuring congestion with a non-invasive monitoring device in heart failure and haemodialysis: CONGEST-HF.
    Eur J Heart Fail. 2024 May 13. doi: 10.1002/ejhf.3290.
    PubMed         Abstract available
    
    
18. VILLASCHI A, Chiarito M, Pagnesi M, Stolfo D, et al
    Frailty according to the 2019 HFA-ESC definition in patients at risk for advanced heart failure: Insights from the HELP-HF registry.
    Eur J Heart Fail. 2024 May 14. doi: 10.1002/ejhf.3234.
    PubMed         Abstract available
    
    
19. BUTLER J, Arshad MS, Khan MS
    Role of anti-obesity drugs in heart failure regardless of ejection fraction.
    Eur J Heart Fail. 2024 May 16. doi: 10.1002/ejhf.3224.
    PubMed        
    
    
20. PECK KH, Dulay MS, Hameed S, Rosano G, et al
    Intentional weight loss in overweight and obese patients with heart failure: A systematic review.
    Eur J Heart Fail. 2024 May 16. doi: 10.1002/ejhf.3270.
    PubMed         Abstract available
    
    
21. KITTIPIBUL V, Mentz RJ, Clare RM, Wojdyla DM, et al
    On-treatment analysis of torsemide versus furosemide for patients hospitalized for heart failure: A post-hoc analysis of TRANSFORM-HF.
    Eur J Heart Fail. 2024 May 15. doi: 10.1002/ejhf.3293.
    PubMed         Abstract available
    
    
22. LASSEN MCH, Ostrominski JW, Inzucchi SE, Claggett BL, et al
    Effect of dapagliflozin in patients with diabetes and heart failure with mildly reduced or preserved ejection fraction according to background glucose-lowering therapy: A pre-specified analysis of the DELIVER trial.
    Eur J Heart Fail. 2024 May 15. doi: 10.1002/ejhf.3269.
    PubMed         Abstract available
    
    
23. VADUGANATHAN M, Claggett BL, Lam CSP, Pitt B, et al
    Finerenone in patients with heart failure with mildly reduced or preserved ejection fraction: Rationale and design of the FINEARTS-HF trial.
    Eur J Heart Fail. 2024 May 14. doi: 10.1002/ejhf.3253.
    PubMed         Abstract available
    
    
24. MALGIE J, Wilde MI, Clephas PRD, Emans ME, et al
    Contemporary guideline-directed medical therapy in de novo, chronic, and worsening heart failure patients: First data from the TITRATE-HF study.
    Eur J Heart Fail. 2024 May 12. doi: 10.1002/ejhf.3267.
    PubMed         Abstract available
    
    
25. KARACAN MN, Doi SN, Yafasova A, Thune JJ, et al
    New York Heart Association functional class and implantable cardioverter-defibrillator in non-ischaemic heart failure with reduced ejection fraction: Extended follow-up of the DANISH trial.
    Eur J Heart Fail. 2024 May 11. doi: 10.1002/ejhf.3239.
    PubMed         Abstract available
    
    
26. SOLOMON SD, Ostrominski JW, Vaduganathan M, Claggett B, et al
    Baseline characteristics of patients with heart failure with mildly reduced or preserved ejection fraction: The FINEARTS-HF trial.
    Eur J Heart Fail. 2024 May 11. doi: 10.1002/ejhf.3266.
    PubMed         Abstract available
    
    
27. BAUERSACHS J, Solomon SD, Anker SD, Antorrena-Miranda I, et al
    Efficacy and safety of CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction: Rationale and design of the HF-REVERT trial.
    Eur J Heart Fail. 2024;26:674-682.
    PubMed         Abstract available
    
    

    
    Int J Cardiol

28. HUANG H, Fu B, Long T, Yu Y, et al
    Implication of geriatric nutritional risk index on treatment response and long-term prognosis in patients with cardiac resynchronization therapy.
    Int J Cardiol. 2024;407:132064.
    PubMed         Abstract available
    
    
29. HUNG KC, Chao CT
    Instrumental outcome modifiers to be considered among patients with acute heart failure.
    Int J Cardiol. 2024;408:132145.
    PubMed        
    
    
30. FEDERICA P, Samantha B, Davide A, Lucia C, et al
    Serum uric acid to eGFR ratio correlates with adverse outcomes in elderly hospitalized for acute heart failure.
    Int J Cardiol. 2024 May 11:132160. doi: 10.1016/j.ijcard.2024.132160.
    PubMed         Abstract available
    
    
31. KAWAI A, Nagatomo Y, Yukino-Iwashita M, Ikegami Y, et al
    Supra-normal and mildly reduced ejection fraction in women -An overlooked vulnerable subpopulation in heart failure.
    Int J Cardiol. 2024 May 12:132166. doi: 10.1016/j.ijcard.2024.132166.
    PubMed         Abstract available
    
    
32. TADAFUMI S
    Pulmonary fluid redistribution during exercise and recovery in chronic heart failure.
    Int J Cardiol. 2024 May 14:132173. doi: 10.1016/j.ijcard.2024.132173.
    PubMed        
    
    

    
    J Am Coll Cardiol

33. KONDO T, Mogensen UM, Talebi A, Gasparyan SB, et al
    Dapagliflozin and Days of Full Health Lost in the DAPA-HF Trial.
    J Am Coll Cardiol. 2024;83:1973-1986.
    PubMed         Abstract available
    
    
34. MATSUMOTO S, Henderson AD, Shen L, Yang M, et al
    Mineralocorticoid Receptor Antagonists in Patients With Heart Failure and Impaired Renal Function.
    J Am Coll Cardiol. 2024 May 6:S0735-1097(24)06945.
    PubMed         Abstract available
    
    
35. FERRO CJ, Townend JN
    Mineralocorticoid Receptor Antagonism in Heart Failure and Chronic Kidney Disease: Short-Term Pain for Long-Term Gain.
    J Am Coll Cardiol. 2024 May 6:S0735-1097(24)06944.
    PubMed        
    
    
36. OSTROMINSKI JW, Claggett BL, Miao ZM, Mc Causland FR, et al
    Cardiovascular-Kidney-Metabolic Overlap in Heart Failure with Mildly Reduced or Preserved Ejection Fraction: A Trial-Level Analysis.
    J Am Coll Cardiol. 2024 May 9:S0735-1097(24)07204.
    PubMed        
    
    

    
    J Card Fail

37. BOORAS M
    My Journey as a Heart Transplantation Patient...and What I Want Providers to Know: Part 1.
    J Card Fail. 2024;30:744-746.
    PubMed        
    
    
38. BOORAS M
    My Journey as a Heart Transplantation Patient...and What I Want Providers to Know: Part II.
    J Card Fail. 2024;30:746-749.
    PubMed        
    
    
39. BOORAS M
    My Journey as a Heart Transplantation Patient...and What I Want Providers to Know-Part III.
    J Card Fail. 2024;30:749-752.
    PubMed        
    
    
40. DANDEL M
    Misleading Impact of Mitral Regurgitation on the Evaluation of Left Ventricular Contractile Function in Heart Failure With Preserved Ejection Fraction.
    J Card Fail. 2024 May 9:S1071-9164(24)00153.
    PubMed        
    
    
41. ALI SZ, Lala-Trindade A, Misra D, Carnicelli AP, et al
    "Time is the Ultimate Commodity": A Call For a Combined Training Pathway in Advanced Heart Failure and Critical Care.".
    J Card Fail. 2024 May 9:S1071-9164(24)00155.
    PubMed        
    
    
42. HAMATANI Y, Teramoto K, Ikeyama-Hideshima Y, Ogata S, et al
    Validation of a Supportive and Palliative Care Indicator Tool among hospitalized patients with heart failure.
    J Card Fail. 2024 May 10:S1071-9164(24)00160.
    PubMed         Abstract available
    
    
43. OSTROMINSKI JW, Aggarwal R, Claggett BL, Kulac IJ, et al
    Generalizability of the Spectrum of Kidney Risk in the FINEARTS-HF Trial to US Adults with Heart Failure.
    J Card Fail. 2024 May 11:S1071-9164(24)00156.
    PubMed        
    
    
44. FELDMAN DI, Babikian S, Feldman T, Curnow R, et al
    Leveraging Remote Patient Monitoring to Effectively Put the Heart Failure Guidelines to Practice.
    J Card Fail. 2024 May 11:S1071-9164(24)00159.
    PubMed        
    
    
45. YAFASOVA A, Doi SN, Thune JJ, Nielsen JC, et al
    Effect of implantable cardioverter-defibrillator in non-ischemic heart failure according to background medical therapy: Extended follow-up of the DANISH trial.
    J Card Fail. 2024 May 13:S1071-9164(24)00157.
    PubMed         Abstract available
    
    

    
    J Thorac Cardiovasc Surg

46. MOVAHEDI F, Pagani FD, Antaki JF
    In search of similarity in adverse events journeys of patients with left ventricular assist devices.
    J Thorac Cardiovasc Surg. 2024;167:2147-2156.
    PubMed         Abstract available
    
    
47. GUZMAN-GOMEZ A, Greenberg JW, Dani A, Villa C, et al
    In the era of outpatient ventricular assist devices, is it time to reconsider the practice of bridging older children to transplant on outpatient inotropes?
    J Thorac Cardiovasc Surg. 2024;167:2206-2214.
    PubMed         Abstract available
    
    

    
    PLoS One

48. AL YOUNIS SM, Hadjileontiadis LJ, Khandoker AH, Stefanini C, et al
    Prediction of heart failure patients with distinct left ventricular ejection fraction levels using circadian ECG features and machine learning.
    PLoS One. 2024;19:e0302639.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge.